RxDoctor Payments Data

Amit Banga, MD

Pulmonary Disease · Stanford, CANPI 1578721841

Payments from drug & device makers

$117,035in general payments, 2019–2025

Across 9 payments — averaging $13,004 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi US Services Inc.$117K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi US Services Inc.9$117,035

How this compares

$117,035 in reported general payments places this provider in the 90th percentile of 1,261 pulmonary disease providers in California.

See all pulmonary disease providers in California

Medicare billing

Part B allowed, 2024
$235,398
Medicare patients
164
Services billed
1,804

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CresembaIsavuconazonium Sulfate16$96,141
Posaconazole82$67,884
EliquisApixaban32$23,382
Everolimus18$20,824
Valganciclovir Hcl41$8,728
Atovaquone15$7,659
Breo ElliptaFluticasone/Vilanterol13$6,187
Tacrolimus86$5,373
Mycophenolate Mofetil37$4,518
Itraconazole36$4,327
Clotrimazole17$983
Acyclovir76$885
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim68$740
Azithromycin44$427
Pantoprazole Sodium46$397

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →